Structural basis of chemokine sequestration by CrmD, a poxvirus-encoded tumor necrosis factor receptor

PLoS Pathogens

Volumn 7, Issue 7, 2011, Pages

  Xue, Xiaoguang ^a   Lu, Qingyu ^a   Wei, Hui ^a   Wang, Dongli ^a   Chen, Dongwei ^b   He, Guangjun ^a   Huang, Li ^c   Wang, Hanzhong ^c   Wang, Xinquan ^a  

^a TSINGHUA UNIVERSITY   (China)

^b Tsinghua University   (China)

^c WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE RESPONSE MODIFIER D; FRACTALKINE; HEPARIN; SMALLPOX VIRUS ENCODED CHEMOKINE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; CX3CL1 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; BINDING AFFINITY; BINDING KINETICS; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ECTROMELIA VIRUS; INHIBITION KINETICS; MUTAGENESIS; NONHUMAN; POXVIRUS; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SMALLPOX VIRUS; STEADY STATE; STRUCTURE ANALYSIS; AMINO ACID SUBSTITUTION; ANIMAL; CELL LINE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MISSENSE MUTATION; MOUSE; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

DNA VIRUSES; ECTROMELIA VIRUS; POXVIRIDAE; VARIOLA VIRUS;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CHEMOKINE CX3CL1; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; VARIOLA VIRUS; VIRAL PROTEINS;

EID: 79960963198     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002162     Document Type: Article

References (60)

1. Baggiolini M, (1998) Chemokines and leukocyte traffic. Nature 392: 565-568.
2. Rossi D, Zlotnik A, (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242.
3. Rot A, von Andrian UH, (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22: 891-928.
4. Charo IF, Ransohoff RM, (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621.
5. Rollins BJ, (1997) Chemokines. Blood 90: 909-928.
6. Allen SJ, Crown SE, Handel TM, (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25: 787-820.
7. Hamel DJ, Sielaff I, Proudfoot AE, Handel TM, (2009) Chapter 4. Interactions of chemokines with glycosaminoglycans. Methods Enzymol 461: 71-102.
8. Lortat-Jacob H, Grosdidier A, Imberty A, (2002) Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci U S A 99: 1229-1234.
9. Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, et al. (2003) Poxviruses and immune evasion. Annu Rev Immunol 21: 377-423.
10. Alcami A, (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3: 36-50.
11. Mantovani A, Bonecchi R, Locati M, (2006) Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 6: 907-918.
12. Graham KA, Lalani AS, Macen JL, Ness TL, Barry M, et al. (1997) The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229: 12-24.
13. Smith CA, Smith TD, Smolak PJ, Friend D, Hagen H, et al. (1997) Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236: 316-327.
14. Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL, (1998) Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol 160: 624-633.
15. Lalani AS, Ness TL, Singh R, Harrison JK, Seet BT, et al. (1998) Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology 250: 173-184.
16. Burns JM, Dairaghi DJ, Deitz M, Tsang M, Schall TJ, (2002) Comprehensive mapping of poxvirus vCCI chemokine-binding protein. Expanded range of ligand interactions and unusual dissociation kinetics. J Biol Chem 277: 2785-2789.
17. Bahar MW, Kenyon JC, Putz MM, Abrescia NG, Pease JE, et al. (2008) Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog 4: e5.
18. Ruiz-Arguello MB, Smith VP, Campanella GS, Baleux F, Arenzana-Seisdedos F, et al. (2008) An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J Virol 82: 917-926.
19. Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, et al. (2000) A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191: 573-578.
20. van Berkel V, Barrett J, Tiffany HL, Fremont DH, Murphy PM, et al. (2000) Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol 74: 6741-6747.
21. Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, et al. (2002) Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111: 343-356.
22. Webb LM, Smith VP, Alcami A, (2004) The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans. Faseb J 18: 571-573.
23. Alexander-Brett JM, Fremont DH, (2007) Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor. J Exp Med 204: 3157-3172.
24. Lalani AS, Graham K, Mossman K, Rajarathnam K, Clark-Lewis I, et al. (1997) The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol 71: 4356-4363.
25. Seet BT, McCaughan CA, Handel TM, Mercer A, Brunetti C, et al. (2003) Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors. Proc Natl Acad Sci U S A 100: 15137-15142.
26. Wang D, Bresnahan W, Shenk T, (2004) Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc Natl Acad Sci U S A 101: 16642-16647.
27. Bryant NA, Davis-Poynter N, Vanderplasschen A, Alcami A, (2003) Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. Embo J 22: 833-846.
28. Johnston JB, McFadden G, (2004) Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes. Cell Microbiol 6: 695-705.
29. Graham SC, Bahar MW, Abrescia NG, Smith GL, Stuart DI, et al. (2007) Structure of CrmE, a virus-encoded tumour necrosis factor receptor. J Mol Biol 372: 660-671.
30. Alejo A, Ruiz-Arguello MB, Ho Y, Smith VP, Saraiva M, et al. (2006) A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc Natl Acad Sci U S A 103: 5995-6000.
31. Alcami A, Saraiva M, (2009) Chemokine binding proteins encoded by pathogens. Adv Exp Med Biol 666: 167-179.
32. Antonets DV, Nepomnyashchikh TS, Shchelkunov SN, (2010) SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family. BMC research notes 3: 271.
33. An X, Liu F, Fang M, Zhu Y, Wang H, (2003) Isolation and identification of a mouse poxvirus and its infectivity. Virologica Sinica 18: 563-565.
34. Carfi A, Smith CA, Smolak PJ, McGrew J, Wiley DC, (1999) Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc Natl Acad Sci U S A 96: 12379-12383.
35. Arnold PL, Fremont DH, (2006) Structural determinants of chemokine binding by an Ectromelia virus-encoded decoy receptor. J Virol 80: 7439-7449.
36. Zhang L, Derider M, McCornack MA, Jao SC, Isern N, et al. (2006) Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta. Proc Natl Acad Sci U S A 103: 13985-13990.
37. Seet BT, Singh R, Paavola C, Lau EK, Handel TM, et al. (2001) Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc Natl Acad Sci U S A 98: 9008-9013.
38. Beck CG, Studer C, Zuber JF, Demange BJ, Manning U, et al. (2001) The viral CC chemokine-binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site. J Biol Chem 276: 43270-43276.
39. Frauenschuh A, Power CA, Deruaz M, Ferreira BR, Silva JS, et al. (2007) Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus. J Biol Chem 282: 27250-27258.
40. Deruaz M, Frauenschuh A, Alessandri AL, Dias JM, Coelho FM, et al. (2008) Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J Exp Med 205: 2019-2031.
41. Smith P, Fallon RE, Mangan NE, Walsh CM, Saraiva M, et al. (2005) Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J Exp Med 202: 1319-1325.
42. Dias JM, Losberger C, Deruaz M, Power CA, Proudfoot AE, et al. (2009) Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3. PLoS One 4: e8514.
43. Gevrey JC, Isaac BM, Cox D, (2005) Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine). J Immunol 175: 3737-3745.
44. Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE, (2005) Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. Annu Rev Biochem 74: 385-410.
45. Proudfoot AE, (2006) The biological relevance of chemokine-proteoglycan interactions. Biochem Soc Trans 34: 422-426.
46. Shaw JP, Johnson Z, Borlat F, Zwahlen C, Kungl A, et al. (2004) The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure 12: 2081-2093.
47. Murphy JW, Cho Y, Sachpatzidis A, Fan C, Hodsdon ME, et al. (2007) Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem 282: 10018-10027.
48. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, et al. (1997) Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. Embo J 16: 6996-7007.
49. Pakianathan DR, Kuta EG, Artis DR, Skelton NJ, Hebert CA, (1997) Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. Biochemistry 36: 9642-9648.
50. Bondue A, Jao SC, Blanpain C, Parmentier M, LiWang PJ, (2002) Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding. Biochemistry 41: 13548-13555.
51. Fernandez EJ, Lolis E, (2002) Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42: 469-499.
52. Otwinowski Z, Borek D, Majewski W, Minor W, (2003) Multiparametric scaling of diffraction intensities. Acta Crystallogr A 59: 228-234.
53. Schneider TR, Sheldrick GM, (2002) Substructure solution with SHELXD. Acta Crystallogr D Biol Crystallogr 58: 1772-1779.
54. Sheldrick GM, (2002) Macromolecular phasing with SHELXE. Z Kristallogr 217: 644-650.
55. Pape T, Schneider TR, (2004) HKL2MAP, a graphical user interface for phasing with SHELX programs. J Appl Crystallogr 37: 843-844.
56. The CCP4 suite: programs for protein crystallography (1994) Acta Crystallogr D Biol Crystallogr 50: 760-763.
57. Langer G, Cohen SX, Lamzin VS, Perrakis A, (2008) Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc 3: 1171-1179.
58. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
59. Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, et al. (2002) PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58: 1948-1954.
60. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674.